Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes

PURPOSE: Rezum is a minimally invasive surgery for benign prostatic hyperplasia. Current guidelines recommend Rezum for prostates < 80 cc, but little data exist describing outcomes in patients with prostates ≥ 80 cc. We compare outcomes after Rezum between men with small < 80 cc (SP) and large...

Descripción completa

Detalles Bibliográficos
Autores principales: Garden, Evan B., Shukla, Devki, Ravivarapu, Krishna T., Kaplan, Steven A., Reddy, Avinash K., Small, Alexander C., Palese, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779102/
https://www.ncbi.nlm.nih.gov/pubmed/33392646
http://dx.doi.org/10.1007/s00345-020-03548-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779102/
https://www.ncbi.nlm.nih.gov/pubmed/33392646
http://dx.doi.org/10.1007/s00345-020-03548-7

Ejemplares similares